1Issacs, JT & Coffey, D (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate 2, Suppl., 33–50.
2Ekman, P (1989) BPH epidemiology and risk factors. Prostate 2, Suppl., 23–33.
3Coward, L, Barnes, NC, Setchell, KDR & Barnes, S (1993) Genistein, daidzein, and their B-glycoside conjugates. Antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 41, 1961–1967.
4Adlercreutz, H, Bannwart, C, Wahala, K, Makela, T, Brunow, G, Hase, T, Arosemena, PJ, Kellis, JT Jr & Vickery, LE (1993) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147–153.
5Leung, SSF, Ho, SC, Woo, J, Lam, TH & Janus, ED (1997) Hong Kong Adult Dietary Survey 1995. Hong Kong: Department of Paediatrics, Chinese University of Hong Kong.
6McCance, RA (1978) McCance & Widdowson's: The Composition of Foods, 4th ed.London: HMSO.
7Yang, Y, Wang, G & Pan, X (2002) Institute of Nutrition & Food Safety, China CDC. China Food Composition 2002. Peking: University Medical Press.
8Dwyer, JT, Goldin, RB, Saul, N, Gaultieri, L, Barakat, S & Adlercreutz, H (1994) Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94, 739–743.
9Anderson, JW (1997) , Boston, MA.
10Barry, MJ, Fowler, FJ Jr, O'Leary, MP, Bruskewitz, RC, Holtgrewe, HL, Mebist, WK & Cockett, AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 148, 1549–1557.
11Chan, AYT, Yiu, MK & Yiu, TF (1999) Diagnosis of BPH and when to refer. Hong Kong Pract 21, 116–124.
12Washburn, RA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46, 153–162.
13Census and Statistics Department (2003) Thematic Household Survey Report No.12: Health Status of Hong Kong Residents; Doctor Consultation; Hospitalization; Dental Consultation; Provision of Medical Benefits by Employers/Companies and Coverage of Medical Insurance Purchased by Individuals; Health Status of Institutional Residents and their Utilization of Medical Services. Hong Kong SAR: Census and Statistics Department.
14Jacobsen, BK, Knutsen, SF & Fraser, GE (1998) Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9, 553–557.
15Hong, SJ, Kim, SI, Kwon, SM, Lee, JR & Chung, BC (2002) Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 43, 236–241.
16Brossner, C, Petritsch, K, Fink, K, Auprich, M, Madersbacher, S, Adlercreutx, H, Rehak, P & Petritsch, P (2004) Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Urology 64, 707–711.
17Weber, KS, Setchell, KDR, Stocco, DM & Lephart, ED (2001) Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5 α reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J Endocrinol 170, 591–599.
18Jarred, RA, McPherson, SJ, Jones, MEE, Simpson, ER & Risbridger, GP (2003) Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKO) mice. Prostate 56, 54–64.
19Kurzer, MS & Xu, X (1997) Dietary phytoestrogens. Annu Rev Nutr 17, 353–381.